Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vivo Cannabis Inc
(OP:
VVCIF
)
N/A
UNCHANGED
Last Price
Updated: 3:09 PM EDT, Apr 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0153
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
April 13, 2023
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow
Via
Benzinga
The Canadian Cannabis Report - Monday, April 10
April 10, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.
Via
Talk Markets
Performance
More News
Read More
The Canadian Cannabis Report - Monday, April 3
April 03, 2023
Via
Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
March 31, 2023
Via
Benzinga
VIVO Cannabis Announces Fourth Quarter 2022 Results
March 28, 2023
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Obtains Final Court Order Approving Its Plan of Arrangement with MediPharm
March 24, 2023
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Signs Agreement To Amend Outstanding Debentures
September 19, 2022
Via
Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
March 22, 2023
Via
Benzinga
VIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of Shareholders
March 21, 2023
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs To Acquire VIVO Cannabis
December 22, 2022
Via
Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
December 22, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, Dec. 19
December 19, 2022
Via
Talk Markets
The Cannabis Canadian Report - Monday, Dec. 5
December 05, 2022
Via
Talk Markets
The Canadian Cannabis Report - Monday, Nov.28
November 28, 2022
Via
Talk Markets
Vivo Cannabis Q3 Revenue Improves 19% YoY Driven By Increased International Sales
November 15, 2022
Via
Benzinga
VIVO Cannabis Announces Third Quarter 2022 Results
November 14, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Third Supplemental Debenture Indenture
October 03, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Agreement to Amend Outstanding Debentures
September 19, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Second Quarter 2022 Results
August 15, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Subsidiary Canna Farms Granted Research License By Health Canada
July 22, 2022
Via
Benzinga
VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada
July 22, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, June 20
June 20, 2022
Via
Talk Markets
VIVO Cannabis Announces First Quarter 2022 Results
May 16, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, May 16
May 16, 2022
Via
Talk Markets
VIVO Cannabis Announces Fourth Quarter 2021 Results
March 31, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.